Cardiac Transplantation and Mechanical Circulatory Support in Amyloidosis
- PMID: 34729523
- PMCID: PMC8543081
- DOI: 10.1016/j.jaccao.2021.05.007
Cardiac Transplantation and Mechanical Circulatory Support in Amyloidosis
Keywords: AL, light chain subtype; ASCT, autologous stem cell transplantation; ATTR-v, variant (hereditary) transthyretin subtype; ATTR-wt, wild-type transthyretin subtype; MCS, mechanical circulatory support; amyloidosis; heart failure; treatment.
Conflict of interest statement
Dr Witteles has served on advisory boards for Pfizer, Alnylam, Eidos, Ionis/Akcea, and Regeneron.
Figures
References
-
- Dubrey S.W., Burke M.M., Hawkins P.N., Banner N.R. Cardiac transplantation for amyloid heart disease: the United Kingdom experience. J Heart Lung Transplant. 2004;23:1142–1153. - PubMed
-
- Kpodonu J., Massad M.G., Caines A., Geha A.S. Outcome of heart transplantation in patients with amyloid cardiomyopathy. J Heart Lung Transplant. 2005;24:1763–1765. - PubMed
-
- Roig E., Almenar L., Gonzalez-Vilchez F. Outcomes of heart transplantation for cardiac amyloidosis: subanalysis of the Spanish registry for heart transplantation. Am J Transplant. 2009;9:1414–1419. - PubMed
-
- Kristen A.V., Kreusser M.M., Blum P. Improved outcomes after heart transplantation for cardiac amyloidosis in the modern era. J Heart Lung Transplant. 2018;37:611–618. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
